Rosiglitazone Versus Placebo in Chronic Stable Angina

Status Terminated

Clinical Trial Summary

We wish to see if the drug rosiglitazone, currently used in the treatment of type 2 diabetes, could be used as a new treatment for angina when compared with placebo in overweight subjects who do not have overt diabetes. The drug will be given for 3 months and the subjects will be have their angina tested, by way of exercise testing, angina quality of life questionnaire and 24-hour ECG monitoring before and after using the drug.

Clinical Trial Description

Chronic stable angina is a common manifestation of ischaemic heart disease. Current mechanical therapies (percutaneous coronary intervention and coronary artery bypass grafting) and pharmacological therapies (nitrates, calcium channel blockers, betablockers and potassium channel activators) main actions are to treat the end product of ischaemic heart disease on chronic stable angina, i.e. the flow limiting stenosis. We postulate that by treating insulin resistance, an upstream factor in the pathogenesis of ischaemic heart disease, we will improve angina by in turn improving endothelial function. We will attempt to demonstrate this by way of full bruce protocol exercise tolerance test, Seattle Angina Questionnaire and 24 hour ST segment analysis before and after treatment with the insulin sensitiser rosiglitazone for three months. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00225355
Study type	Interventional
Source	University of Glasgow
Contact
Status	Terminated
Phase	Phase 4
Start date	February 2006
Completion date	November 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05563701` - Evaluation of the LVivo Image Quality Scoring (IQS)
Recruiting	`NCT02773615` - CT Perfusion Added to CT Angiography
Active, not recruiting	`NCT04475380` - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Terminated	`NCT02548611` - Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention	Phase 4
Completed	`NCT02264717` - Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease	N/A
Completed	`NCT02440893` - Understanding the Effect of Metformin on Corus CAD (or ASGES)
Completed	`NCT01486030` - Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
Completed	`NCT01425359` - Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina	Phase 4
Completed	`NCT01604486` - Natural Ischaemic Preconditioning Before First Myocardial Infarction	N/A
Completed	`NCT00811772` - Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis	N/A
Completed	`NCT00131183` - Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina	Phase 4
Completed	`NCT00184444` - Effect of Increased Oxygenation in the Air During Endurance Training in Stable Angina Pectoris Patients	N/A
Completed	`NCT00235404` - Randomized Controlled Trial of Health Care to Elderly Patients.	N/A
Terminated	`NCT00157742` - Comparison of SCS and PMR in Patients With Refractory Angina Pectoris	Phase 4
Completed	`NCT00000510` - Platelet-Inhibitor Drug Trial in Coronary Angioplasty	Phase 3
Completed	`NCT00005148` - Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships	N/A
Not yet recruiting	`NCT03657758` - Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]	Phase 4
Completed	`NCT05050773` - Registry Study of Medical Therapy in Patients With Angina Pectoris(GREAT)
Completed	`NCT00093223` - A Safety Study of ABI-007 for In-Stent Restenosis	Phase 2
Active, not recruiting	`NCT02508714` - Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents	N/A